1. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581–611.
2. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic implications. Semin Oncol. 2002;29:10–14.
3. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding grow endothelial cells. Biochem Biophys Res Comm. 1989;161:851–858.
4. Tuñón J, Ruiz-Moreno JM, Mertin-Ventura JL, et al. Cardiovascular risn and antioangiogenic therapy for age-related macular degeneration. Surv Ophthalmol. 2009;54(3): 339–348.
5. Zachary I. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol. 2001;280:C1375–C1386.
6. van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of ocular neovascularization: promises and potential problems. JAMA. 2005;293:1509–1513.
7. Dafer RM, Schneck M, Friberg TR, et al. Intravitreal ranibizumab and bevacizumab: a review of risk. Sem Ophthalmol. 2007;22:201–204.
8. Duan Y, Mo J, Klein R, et al. Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology. 2007;114:4.
9. Hurwitz H, Fehrenbacher L, Novotny W Bevacizumab plus irinotecan, flurouracil, and leicovorin for metastatic colorectal cancer. N Eng J Med. 2004; 350:2335–2342.
10. Chakravarthy U, Adamis AP, Cunningham ET Jr, et al. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology. 2006;113:1508–1525.
11. D’Amico DJ, Masonson HN, et al. VEGF Inhibition Study in Ocular Neovascularization (VISION) Clinical Trial Group. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology. 2006;113:992–1001.
12. Brown DM, Michels M, Kaiser PK, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116:57–65.
Only gold members can continue reading.
Log In or
Register to continue
Related
Stay updated, free articles. Join our Telegram channel
